Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 99
  1. Nov 19, 2025 · 01:22 · APS

    Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical

    Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical

    01
  2. Nov 18, 2025 · 18:00 · ONCO

    Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development

    Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development

    02
  3. Nov 18, 2025 · 17:53 · AIAI

    Netramark signs four AI contracts with pharma company

    Netramark signs four AI contracts with pharma company

    03
  4. Nov 18, 2025 · 17:08 · HEM

    Hemostemix Closes CDN$280,594 Private Placement

    Hemostemix Closes CDN$280,594 Private Placement

    04
  5. Nov 18, 2025 · 16:43 · NGEN

    NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development

    NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development

    05
  6. Nov 18, 2025 · 16:15 · PRN

    Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease

    Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease

    06
  7. Nov 18, 2025 · 12:38 · HLS

    HLS gets approval for Nilemdo; Nezlizet needs more data

    HLS gets approval for Nilemdo; Nezlizet needs more data

    07
  8. Nov 18, 2025 · 12:31 · ALGO

    Light AI completes V1.0 diagnostic software system

    Light AI completes V1.0 diagnostic software system

    08
  9. Nov 18, 2025 · 12:19 · LSL

    LSL Pharma completes acquisition of Laboratoire Du-Var

    LSL Pharma completes acquisition of Laboratoire Du-Var

    09
  10. Nov 18, 2025 · 11:43 · MSCL

    Satellos research published in Nature Comms

    Satellos research published in Nature Comms

    10
  11. Nov 18, 2025 · 11:19 · FNDX

    Fendx signs MOU with Aquaox on green pathogen agents

    Fendx signs MOU with Aquaox on green pathogen agents

    11
  12. Nov 18, 2025 · 08:31 · DTR

    DiagnosTear Technologies Inc. Announces Closing of Private Placement of Units

    DiagnosTear Technologies Inc. Announces Closing of Private Placement of Units

    12
  13. Nov 18, 2025 · 08:30 · AIAI

    NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights

    NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights

    13
  14. Nov 18, 2025 · 08:30 · FRX

    Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

    Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

    14
← Newer Older →